CNBC's Michael Bloom contributed to this report. The stock popped another 7% in the premarket Tuesday. Cash, cash equivalents, and marketable securities of 75.3 million as of March 31, 2023. Quanterix shares have been on fire this year, surging more than 38%. Repurchased 0.3 million shares of common stock at an average price of 1.56 per share for an aggregate purchase price of approximately 0.5 million. "We see QTRX as a pure play on the neurology diagnostics market with a leading, highly sensitive, IP protected technology platform in Simoa," he added. "Simply put, given the large in Alzheimer's, the market leading sensitivity of the Simoa platform and the clear advantages of using blood-based tests in neurological drug trial design, we believe QTRX has a significant opportunity for future growth," Sykes said. Sykes also noted Quanterix's cost base has improved more than the market anticipated. QTRX YTD mountain Quanterix stock YTD Analyst Matthew Sykes highlighted the company's potential ability to be a leader in diagnostics related to Alzheimer's disease, as well as companion diagnostics testing for other conditions including amyotrophic lateral sclerosis (ALS), multiple sclerosis and Huntington's disease. Co-Diagnostics is a manufacturer of PCR tests and also holds two patents on specific PCR methods that increase the tests accuracy. The company specializes in digitizing biomarker analysis, which is used to screen for potential disease and sickness in blood tissue or serum. That equates to more than 40% upside from Monday's $19.23 close. The firm upgraded Quanterix stock to buy from neutral Tuesday, with a $27 per share price target. Goldman Sachs is optimistic Quanterix can capitalize on a stronger cost base and advancements in companion diagnostics. At the end of 2019, Co-Diagnostics financial reports told a story of a struggling company. From a penny stock to multiple states testing source. Personal Loans for 670 Credit Score or Lower A spokesperson for the SEC also declined to comment. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis. Personal Loans for 580 Credit Score or Lower A high-level overview of Co-Diagnostics, Inc. Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. Best Debt Consolidation Loans for Bad Credit
0 Comments
Leave a Reply. |